Caris Life Sciences (CAI) news
Recent news
Thermo Fisher Scientific Inc: TD Cowen raises target price to $760 from $675
TD Cowen has revised its price target for Thermo Fisher Scientific Inc (TMO), raising it to $760 from a previous estimate of $675. The adjustment reflects the firm’s updated assessment of the company’s financial outlook and market positioning. While no specific earnings or operational data from…
AInvest Wire · 5h agoSitharaman: Private capital is moving into India
India’s private equity and venture capital ecosystem has shown resilience amid global economic uncertainties, with investment volumes and values expected to grow in 2025. January 2025 marked a strong start, with PE/VC investments rising 37% month-on-month, despite a 9% decline compared to January…
AInvest Wire · 6h agoAevis Victoria SA – Swiss medical network enters into a partnership with Phoenix Pharma Switzerland in Ticino
Aevis Victoria SA, a Swiss-based holding company with interests in healthcare, life sciences, and other sectors, has announced a partnership with Phoenix Pharma Switzerland in the Ticino region. The collaboration is expected to enhance the delivery of medical services and expand the network's…
AInvest Wire · 23h agoShares of Caris Life Sciences (CAI) climbed nearly 7% intraday after Bank of Securities maintained a Buy rating and raised its price target from $23 to $35.
Shares of Caris Life Sciences (CAI) rose nearly 7% during intraday trading following an updated analyst report from Bank of Securities. The firm reaffirmed its Buy rating for the stock and increased its price target from $23 to $35, citing improved fundamentals and strategic momentum. The upward…
AInvest Wire · 3d agoCanada announces new investment for radiopharmaceutical
On October 8, 2026, the Canadian government announced a new investment in Jubilant Radiopharma, a life sciences company, to support the production of medical technologies. The investment, led by the Innovation, Science and Economic Development Canada, aims to enhance the development and…
AInvest Wire · 4d agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.